University of Technology Sydney secures contract for Cancer Australia has executed a contract with the University of Technology, as represented by the Centre for Health Economics Research and Evaluation (CHERE) as the supplier for the Health- and Pharmaco-economics (HE) National Technical Service (NTS). CHERE will provide Multi-site Collaborative Cancer Clinical Trials Groups with expert advice and support for the inclusion of HE measures/sub-studies into investigator-initiated and industry-independent cancer clinical trial concepts and protocols for the period 1 July 2025 to 30 June 2027.

Australia, July 3 -- Australia based University of Technology Sydney has secured contract from Cancer Australia for Cancer Australia has executed a contract with the University of Technology, as represented by the Centre for Health Economics Research and Evaluation (CHERE) as the supplier for the Health- and Pharmaco-economics (HE) National Technical Service (NTS). CHERE will provide Multi-site Collaborative Cancer Clinical Trials Groups with expert advice and support for the inclusion of HE measures/sub-studies into investigator-initiated and industry-independent cancer clinical trial concepts and protocols for the period 1 July 2025 to 30 June 2027.. The value of the contract is worth 656,733.00 AUD.

Published by HT Digital Content Servi...